Minireview: cracking the metabolic code for thyroid hormone signaling.

Cells are not passive bystanders in the process of hormonal signaling and instead can actively customize hormonal action. Thyroid hormone gains access to the intracellular environment via membrane transporters, and while diffusing from the plasma membrane to the nucleus, thyroid hormone signaling is modified via the action of the deiodinases. Although the type 2 deiodinase (D2) converts the prohormone T(4) to the biologically active T(3), the type 3 deiodinase (D3) converts it to reverse T(3), an inactive metabolite. D3 also inactivates T(3) to T(2), terminating thyroid hormone action. Therefore, D2 confers cells with the capacity to produce extra amounts of T(3) and thus enhances thyroid hormone signaling. In contrast expression of D3 results in the opposite action. The Dio2 and Dio3 genes undergo transcriptional regulation throughout embryonic development, childhood, and adult life. In addition, the D2 protein is unique in that it can be switched off and on via an ubiquitin regulated mechanism, triggered by catalysis of T(4). Induction of D2 enhances local thyroid hormone signaling and energy expenditure during activation of brown adipose tissue by cold exposure or high-fat diet. On the other hand, induction of D3 in myocardium and brain during ischemia and hypoxia decreases energy expenditure as part of a homeostatic mechanism to slow down cell metabolism in the face of limited O(2) supply.

[1]  J. Harney,et al.  Human Type 3 Iodothyronine Selenodeiodinase Is Located in the Plasma Membrane and Undergoes Rapid Internalization to Endosomes* , 2003, The Journal of Biological Chemistry.

[2]  M. Berry,et al.  Type I iodothyronine deiodinase is a selenocysteine-containing enzyme , 1991, Nature.

[3]  J. Auwerx,et al.  Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation , 2006, Nature.

[4]  R. H. Bassett,et al.  Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts , 2010, Proceedings of the National Academy of Sciences.

[5]  M. Patti,et al.  The chemical chaperones tauroursodeoxycholic and 4‐phenylbutyric acid accelerate thyroid hormone activation and energy expenditure , 2011, FEBS letters.

[6]  J. Harney,et al.  The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue. , 2001, The Journal of clinical investigation.

[7]  Arturo Hernandez,et al.  Insights into the role of deiodinases from studies of genetically modified animals. , 2005, Thyroid : official journal of the American Thyroid Association.

[8]  A. Bianco,et al.  Regulation of thyroid hormone activation via the liver X-receptor/retinoid X-receptor pathway. , 2010, The Journal of endocrinology.

[9]  C. Fekete,et al.  Role of thyroid hormone deiodination in the hypothalamus. , 2005, Thyroid : official journal of the American Thyroid Association.

[10]  W. Rand,et al.  Lipopolysaccharide induces type 2 iodothyronine deiodinase in the mediobasal hypothalamus: implications for the nonthyroidal illness syndrome. , 2004, Endocrinology.

[11]  J. Harney,et al.  The Small Polyphenolic Molecule Kaempferol Increases Cellular Energy Expenditure and Thyroid Hormone Activation , 2007, Diabetes.

[12]  A. Bianco,et al.  Adaptive Activation of Thyroid Hormone and Energy Expenditure , 2005, Bioscience reports.

[13]  P. Davis,et al.  Molecular aspects of thyroid hormone actions. , 2010, Endocrine reviews.

[14]  J. Harney,et al.  The Iodothyronine Selenodeiodinases Are Thioredoxin-fold Family Proteins Containing a Glycoside Hydrolase Clan GH-A-like Structure* , 2003, Journal of Biological Chemistry.

[15]  A. Bianco,et al.  Intracellular conversion of thyroxine to triiodothyronine is required for the optimal thermogenic function of brown adipose tissue. , 1987, The Journal of clinical investigation.

[16]  M. Patti,et al.  Type 2 deiodinase expression is induced by peroxisomal proliferator-activated receptor-gamma agonists in skeletal myocytes. , 2009, Endocrinology.

[17]  J. Harney,et al.  Selective proteolysis of human type 2 deiodinase: a novel ubiquitin-proteasomal mediated mechanism for regulation of hormone activation. , 2000, Molecular Endocrinology.

[18]  J. Harney,et al.  The E3 Ubiquitin Ligase TEB4 Mediates Degradation of Type 2 Iodothyronine Deiodinase , 2009, Molecular and Cellular Biology.

[19]  A. Butte,et al.  Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. , 2000, The New England journal of medicine.

[20]  E. Murphy,et al.  The thyroid and the skeleton , 2004, Clinical endocrinology.

[21]  J. Harney,et al.  The thyroid hormone-inactivating deiodinase functions as a homodimer. , 2008, Molecular endocrinology.

[22]  J. Harney,et al.  Endoplasmic reticulum-associated degradation of the human type 2 iodothyronine deiodinase (D2) is mediated via an association between mammalian UBC7 and the carboxyl region of D2. , 2003, Molecular endocrinology.

[23]  J. Harney,et al.  In vivo dimerization of types 1, 2, and 3 iodothyronine selenodeiodinases. , 2003, Endocrinology.

[24]  A. Hollenberg The role of the thyrotropin-releasing hormone (TRH) neuron as a metabolic sensor. , 2008, Thyroid : official journal of the American Thyroid Association.

[25]  J. Harney,et al.  Transforming growth factor-beta promotes inactivation of extracellular thyroid hormones via transcriptional stimulation of type 3 iodothyronine deiodinase. , 2005, Molecular endocrinology.

[26]  Eric Paradis,et al.  A central thermogenic-like mechanism in feeding regulation: an interplay between arcuate nucleus T3 and UCP2. , 2007, Cell metabolism.

[27]  T. Visser,et al.  Iodothyronine deiodinase enzyme activities in bone , 2008, Bone.

[28]  T. Horvath,et al.  Fasting-induced increase in type II iodothyronine deiodinase activity and messenger ribonucleic acid levels is not reversed by thyroxine in the rat hypothalamus. , 1998, Endocrinology.

[29]  A. Bianco,et al.  Paracrine signaling by glial cell-derived triiodothyronine activates neuronal gene expression in the rodent brain and human cells. , 2010, The Journal of clinical investigation.

[30]  W. Rand,et al.  Neuropeptide Y1 and Y5 receptors mediate the effects of neuropeptide Y on the hypothalamic-pituitary-thyroid axis. , 2002, Endocrinology.

[31]  A. Bianco,et al.  Bacterial lipopolysaccharide (LPS)-induced type 2 iodothyronine deiodinase (D2) activation in the mediobasal hypothalamus (MBH) is independent of the LPS-induced fall in serum thyroid hormone levels , 2005, Brain Research.

[32]  P. Larsen,et al.  Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes , 2007, Proceedings of the National Academy of Sciences.

[33]  R. DePinho,et al.  The FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and muscle regeneration. , 2010, The Journal of clinical investigation.

[34]  J. Hall,et al.  Disruption of Thyroid Hormone Activation in Type 2 Deiodinase Knockout Mice Causes Obesity With Glucose Intolerance and Liver Steatosis Only at Thermoneutrality , 2011, Diabetes.

[35]  P. Laurberg,et al.  Biologic variation is important for interpretation of thyroid function tests. , 2003, Thyroid : official journal of the American Thyroid Association.

[36]  J. Harney,et al.  Metabolic Instability of Type 2 Deiodinase Is Transferable To Stable Proteins Independently of Subcellular Localization* , 2006, Journal of Biological Chemistry.

[37]  T. Visser,et al.  Genetic variation in thyroid hormone pathway genes; polymorphisms in the TSH receptor and the iodothyronine deiodinases. , 2006, European journal of endocrinology.

[38]  J. Harney,et al.  Characterization of the 5'-flanking and 5'-untranslated regions of the cyclic adenosine 3',5'-monophosphate-responsive human type 2 iodothyronine deiodinase gene. , 2000, Endocrinology.

[39]  J. Harney,et al.  Type 2 iodothyronine selenodeiodinase is expressed throughout the mouse skeleton and in the MC3T3-E1 mouse osteoblastic cell line during differentiation. , 2005, Endocrinology.

[40]  J. Harney,et al.  Hypoxia-inducible factor induces local thyroid hormone inactivation during hypoxic-ischemic disease in rats. , 2008, The Journal of clinical investigation.

[41]  J. Harney,et al.  Ubiquitination-Induced Conformational Change within the Deiodinase Dimer Is a Switch Regulating Enzyme Activity , 2007, Molecular and Cellular Biology.

[42]  L. Braverman,et al.  Werner and Ingbar's the Thyroid: A Fundamental and Clinical Text , 1991 .

[43]  A. Bianco,et al.  Activation and inactivation of thyroid hormone by deiodinases: Local action with general consequences , 2008, Cellular and Molecular Life Sciences.

[44]  J. Bassett,et al.  Local control of thyroid hormone action: role of type 2 deiodinase Deiodinases: the balance of thyroid hormone , 2011 .

[45]  A. Bianco,et al.  Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. , 2008, Endocrine reviews.

[46]  S. Pallud,et al.  Regulation of Type 3 Iodothyronine Deiodinase Expression in Cultured Rat Astrocytes: Role of the Erk Cascade. , 1999, Endocrinology.

[47]  P. Larsen,et al.  Cellular and structural biology of the deiodinases. , 2005, Thyroid : official journal of the American Thyroid Association.

[48]  J. Harney,et al.  Characterization of the 5'-Flanking and 5'-Untranslated Regions of the Cyclic Adenosine 3',5'-Monophosphate-Responsive Human Type 2 Iodothyronine Deiodinase Gene1. , 2000, Endocrinology.

[49]  A. Bianco,et al.  Deiodinase-mediated thyroid hormone inactivation minimizes thyroid hormone signaling in the early development of fetal skeleton. , 2008, Bone.

[50]  C. Hessenius,et al.  Evidence for Circadian Variations of Thyroid Hormone Concentrations and Type II 5′‐Iodothyronine Deiodinase Activity in the Rat Central Nervous System , 1997, Journal of neurochemistry.

[51]  J. Harney,et al.  Deubiquitination of type 2 iodothyronine deiodinase by von Hippel-Lindau protein-interacting deubiquitinating enzymes regulates thyroid hormone activation. , 2003, The Journal of clinical investigation.

[52]  C. Tabin,et al.  The Hedgehog-inducible ubiquitin ligase subunit WSB-1 modulates thyroid hormone activation and PTHrP secretion in the developing growth plate , 2005, Nature Cell Biology.

[53]  J. Harney,et al.  Distinct subcellular localization of transiently expressed types 1 and 2 iodothyronine deiodinases as determined by immunofluorescence confocal microscopy. , 2000, Endocrinology.

[54]  J. Harney,et al.  Ubc6p and ubc7p are required for normal and substrate-induced endoplasmic reticulum-associated degradation of the human selenoprotein type 2 iodothyronine monodeiodinase. , 2002, Molecular endocrinology.

[55]  M. Patti,et al.  Absence of thyroid hormone activation during development underlies a permanent defect in adaptive thermogenesis. , 2010, Endocrinology.

[56]  A. Bianco,et al.  Reawakened interest in type III iodothyronine deiodinase in critical illness and injury , 2008, Nature Clinical Practice Endocrinology &Metabolism.

[57]  P. Larsen,et al.  Regional distribution of type 2 thyroxine deiodinase messenger ribonucleic acid in rat hypothalamus and pituitary and its regulation by thyroid hormone. , 1997, Endocrinology.

[58]  T. Visser,et al.  Minireview: Pathophysiological importance of thyroid hormone transporters. , 2009, Endocrinology.

[59]  A. Bianco,et al.  Thyroxine 5'-Deiodination Mediates Norepinephrine-Induced Lipogenesis in Dispersed Brown Adipocytes. , 1998, Endocrinology.

[60]  J. Bernal,et al.  The type 2 iodothyronine deiodinase is expressed primarily in glial cells in the neonatal rat brain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.